PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 129 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 2.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $34,607,000 | -5.6% | 3,769,795 | 0.0% | 0.62% | -20.1% |
| Q1 2021 | $36,642,000 | -9.8% | 3,769,795 | -4.8% | 0.77% | -4.1% |
| Q4 2020 | $40,627,000 | +42.5% | 3,959,741 | +40.1% | 0.80% | +15.7% |
| Q3 2020 | $28,518,000 | +250.8% | 2,826,327 | +193.4% | 0.69% | +169.0% |
| Q1 2020 | $8,130,000 | +134.4% | 963,212 | +142.9% | 0.26% | +132.4% |
| Q4 2019 | $3,469,000 | -61.8% | 396,472 | +281.2% | 0.11% | -77.1% |
| Q2 2017 | $9,090,000 | – | 104,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |